Nucleus RadioPharma has announced the appointment of Dr Stephen M. Hahn as their new CEO. His extensive experience in regulatory, clinical, and operational leadership is expected to enhance the company's ability to scale access to radiopharmaceutical therapies.
Who to call at Nucleus RadioPharma, and when
A new leader at Nucleus RadioPharma brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Nucleus RadioPharma
Location
Davidson, North Carolina, United States
About
Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, Nucleus provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Its technology platforms are at the forefront of radiopharmaceutical research, designed to advance new therapies through clinical trials to commercialization.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DavidsonManufacturingBiotechnologyHealth Carepharmaceuticals